de Gruijl, T. D., Koster, B. D., van den Hout, M. F., Sluijter, B. J., Molenkamp, B. G., Vuylsteke, R. J., . . . van den Eertwegh, A. (2015). Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: Long-term follow-up of three randomized clinical trials. J Immunother Cancer.
Citação norma Chicagode Gruijl, Tanja D., et al. "Adjuvant Treatment of Early-stage Melanoma By Local I.d. Administration of Low-dose CpG-B and GM-CSF Increases Recurrence-free Survival: Long-term Follow-up of Three Randomized Clinical Trials." J Immunother Cancer 2015.
Citação norma MLAde Gruijl, Tanja D., et al. "Adjuvant Treatment of Early-stage Melanoma By Local I.d. Administration of Low-dose CpG-B and GM-CSF Increases Recurrence-free Survival: Long-term Follow-up of Three Randomized Clinical Trials." J Immunother Cancer 2015.